Ages & Stages Questionnaires®, Third Edition (ASQ-3)

Parent-completed developmental screening for children 1–66 months across five domains.

Type: Developmental screening Domains: Communication, Gross/Fine Motor, Problem Solving, Personal-Social Age range: 1–66 months Version: v1.0

What it evaluates

ASQ-3 is a standardized, parent-centric questionnaire that screens developmental progress in children from 1 to 66 months. Each age-specific form assesses five domains—Communication, Gross Motor, Fine Motor, Problem Solving, and Personal-Social—to identify children who may need further developmental assessment, closer monitoring, or routine follow-up.

How to respond / Requirements

  • Who completes: primarily parents/caregivers; trained professionals may assist if they know the child well.
  • Administration time: ~10–15 minutes; scoring time: ~2–3 minutes.
  • Who scores: professionals (e.g., nurses, pediatricians, home visitors, teachers, EI providers).
  • Use the questionnaire that matches the child’s age interval; provide clear examples and materials for items when applicable.
  • Training is not required but encouraged (intro and train-the-trainer seminars available through Brookes On Location).

Required inputs / Materials

  • Age-appropriate ASQ-3 questionnaire (there are 21 forms covering 1–66 months).
  • Basic toys/objects for demonstrations when applicable (e.g., blocks for stacking, small balls, crayons, books).
  • Quiet setting and caregiver familiar with the child’s daily skills.
  • Optional: translated forms (Arabic, English, French, Spanish, Vietnamese).

Age intervals and forms

There are 21 questionnaires. Common intervals (months): 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 27/30, 33, 36, 42, 48, 54, 60 (programs may also use 1 and 66 months as bookends).

Each questionnaire has 30 items (6 per domain) plus overall concerns prompts for caregivers.

Output and interpretation

ASQ-3 yields five raw domain scores. Each is compared to age-specific cutoff points to guide action:

  • Below cutoff: refer for further developmental evaluation.
  • Monitor zone (near cutoff): provide developmental activities, rescreen in 1–2 intervals.
  • Above cutoff: child appears to be developing typically; continue routine surveillance.

Scores summarize caregiver-reported ability; consider clinical context, observation, and other screens when available.

Evidence and validation

  • Standardization sample: 18,527 questionnaires representing 15,138 children from diverse backgrounds.
  • Reliability: test–retest ≈ 0.92; inter-rater ≈ 0.93.
  • Validity: 0.82–0.88; Sensitivity: ≈ 0.86; Specificity: ≈ 0.85.
  • Supported by AAP guidance for routine developmental screening in the medical home.

Clinical considerations and limitations

  • Parent-report strengths: captures skills across settings; quick and acceptable. Limitations include recall bias or misunderstanding of items—offer clarification and examples.
  • Use translated/validated forms when language barriers exist; ensure literacy support as needed (items are written at ~4th–6th grade level).
  • ASQ-3 is a screening tool, not diagnostic; abnormal or borderline results require follow-up assessment.
  • Programs should adopt a clear rescreening interval and referral pathway; document overall caregiver concerns even if domain scores are normal.

Practical integration

  • Embed ASQ-3 in well-child visits, home visiting, early education intake, or community screens.
  • Provide families with simple activities to support skills between screens; schedule rescreen per local policy (e.g., 2–3 months later if in monitor zone).
  • Share results with caregivers in plain language; align with EI/therapy referral criteria in your jurisdiction.
  • Use the “overall concerns” section to trigger referrals even when scores are above cutoffs.

Version and sources

Version: v1.0 — Ages & Stages Questionnaires® (ASQ-3) overview.

Primary sources and key references:

  1. Official ASQ-3 product page and technical specifications.
  2. Lipkin PH, Macias MM; AAP. Promoting Optimal Development: Developmental Surveillance and Screening. Pediatrics. 2020;145(1):e2019344.
  3. AAP Policy Statement (2006): Identifying Infants and Young Children with Developmental Disorders. Pediatrics. 118:405–420.
  4. Macy M. The evidence behind developmental screening instruments. Infants & Young Children. 2012;25(1):16–61.
  5. Valleley RJ, Roane BM. Review of ASQ-3. Mental Measurements Yearbook. 2010.

Implementation notes

Build a simple workflow: select the correct age form, coach caregivers briefly, score immediately, share results, give activities, and schedule rescreening when indicated. Track referrals and outcomes to improve local performance (sensitivity/specificity can vary with cutoffs and population).

Disclaimer: This page is an evidence-based summary for clinicians and does not replace local guidelines or clinical judgment. Follow your institutional protocols and regulatory requirements.